Thermo Fisher saw accelerating revenue growth in pharma/biotech, AI-driven cost efficiencies, and attractive valuations. See here for more on TMO stock.
Thermo Fisher Stock: Growth Acceleration And Margin Expansion Should Drive Upside (TMO)

5
Thermo Fisher saw accelerating revenue growth in pharma/biotech, AI-driven cost efficiencies, and attractive valuations. See here for more on TMO stock.